Bin Yu is AvalonAI’s chief technology officer, with more than 20 years of experience in healthcare, retail, and hospitality. His healthcare work focuses on cost analysis, utilization patterns, and outcome predictions using machine learning and systems biology models.
Christopher Malter is CEO of AvalonAI, founder and managing partner of Mikal Ventures, and founder and CEO of IMC. Christopher Malter has raised over $100 million for early-stage life sciences and tech companies and works on corporate profitability.
Michael Suk is a strategic advisor to AvalonAI and a board-certified orthopedic surgeon. He was elected to the American Medical Association Board of Trustees in June 2019 and became board chair in June 2024.
Michael Nikunen co-founded MSQ Advisory and assists companies with growth strategy and entry into the employer-provided benefit market, including go-to-market strategy development.